These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25261380)

  • 1. pH-sensitive carbonate apatite nanoparticles as DNA vaccine carriers enhance humoral and cellular immunity.
    He P; Takeshima SN; Tada S; Akaike T; Ito Y; Aida Y
    Vaccine; 2014 Oct; 32(47):6199-205. PubMed ID: 25261380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of antigen-specific immunity by pH-sensitive carbonate apatite as a potent vaccine carrier.
    Hebishima T; Tada S; Takeshima SN; Akaike T; Ito Y; Aida Y
    Biochem Biophys Res Commun; 2011 Dec; 415(4):597-601. PubMed ID: 22074821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cell-mediated immunity against Mycobacterium tuberculosis using DNA vaccines encoding cytotoxic and helper T-cell epitopes of the 38-kilodalton protein.
    Fonseca DP; Benaissa-Trouw B; van Engelen M; Kraaijeveld CA; Snippe H; Verheul AF
    Infect Immun; 2001 Aug; 69(8):4839-45. PubMed ID: 11447158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antibody response by high mobility group box protein-1-based DNA immunization.
    Kimura R; Shiibashi R; Suzuki M; Hayashizaki Y; Chiba J
    J Immunol Methods; 2010 Sep; 361(1-2):21-30. PubMed ID: 20470779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle formulation enhanced protective immunity provoked by PYGPI8p-transamidase related protein (PyTAM) DNA vaccine in Plasmodium yoelii malaria model.
    Cherif MS; Shuaibu MN; Kodama Y; Kurosaki T; Helegbe GK; Kikuchi M; Ichinose A; Yanagi T; Sasaki H; Yui K; Tien NH; Karbwang J; Hirayama K
    Vaccine; 2014 Apr; 32(17):1998-2006. PubMed ID: 24440206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid DNA vaccines are effective in the absence of IFNgamma.
    Hassett DE; Zhang J; Whitton JL
    Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy.
    Minigo G; Scholzen A; Tang CK; Hanley JC; Kalkanidis M; Pietersz GA; Apostolopoulos V; Plebanski M
    Vaccine; 2007 Jan; 25(7):1316-27. PubMed ID: 17052812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of plasmid DNA immunogenicity with linear polyethylenimine.
    Grant EV; Thomas M; Fortune J; Klibanov AM; Letvin NL
    Eur J Immunol; 2012 Nov; 42(11):2937-48. PubMed ID: 22886924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses.
    Shim BS; Park SM; Quan JS; Jere D; Chu H; Song MK; Kim DW; Jang YS; Yang MS; Han SH; Park YH; Cho CS; Yun CH
    BMC Immunol; 2010 Dec; 11():65. PubMed ID: 21194475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant effect of plasmid vector-expressed OX40L on candidate DNA vaccine against type B heptatitis].
    Du X; Kang Y; Wang X; Wang J; Zhao G; Wang B
    Wei Sheng Wu Xue Bao; 2009 Mar; 49(3):357-62. PubMed ID: 19623960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.
    Guan X; Nishikawa M; Takemoto S; Ohno Y; Yata T; Takakura Y
    J Gene Med; 2010 Mar; 12(3):301-9. PubMed ID: 20084616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pH-sensitive fusogenic 3-methyl-glutarylated hyperbranched poly(glycidol)-conjugated liposome induces antigen-specific cellular and humoral immunity.
    Hebishima T; Yuba E; Kono K; Takeshima SN; Ito Y; Aida Y
    Clin Vaccine Immunol; 2012 Sep; 19(9):1492-8. PubMed ID: 22815149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.
    Powell TJ; Palath N; DeRome ME; Tang J; Jacobs A; Boyd JG
    Vaccine; 2011 Jan; 29(3):558-69. PubMed ID: 20951665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of the DNA vaccine of major outer membrane protein of Neisseria gonorrhoeae and investigation of immune effects after vaccination].
    Liao F; He C; Liu HP; Song QF; Yan J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Nov; 40(6):422-6. PubMed ID: 17313744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological adjuvant effect of Boswellia serrata (BOS 2000) on specific antibody and cellular response to ovalbumin in mice.
    Gupta A; Khajuria A; Singh J; Singh S; Suri KA; Qazi GN
    Int Immunopharmacol; 2011 Aug; 11(8):968-75. PubMed ID: 21371582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.
    Wieland A; Riedl P; Reimann J; Schirmbeck R
    Vaccine; 2009 Dec; 28(1):114-9. PubMed ID: 19818719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis.
    Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ
    Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.